The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
Development of therapeutic antibodies for the treatment of diseases.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jan 2020 – Oct 2024Where it's discussed
-
X / Twitter134 posts
-
News27 articles
-
YouTube8 videos
-
Blogs6 articles
AI synopsis
What people are saying
Several discussions support the article's positive perspective, with posts mentioning breakthroughs that date back to the 1980s and emphasizing the market growth to over $122 billion, using phrases like 'most important advancements in medicine' and 'transformative potential,' which showcase both interest and recognition of impact. The tone and references to historical milestones and future possibilities indicate a general consensus of enthusiasm and significance.
Most social discussions show support and enthusiasm for the article's portrayal of the advancements and significance of therapeutic antibodies.
Many posts express high interest, referencing specific developments, historical milestones, and future potential, indicating active engagement with the topic.
Posts include technical details, historical context, and resource-sharing, demonstrating a moderate depth of engagement rather than superficial mentions.
The discussions highlight the substantial influence of therapeutic antibodies, including their market size and medical breakthroughs, reflecting high perceived impact.
Abstract in brief
- Antibody engineering has significantly advanced since the first monoclonal antibody was approved in 1986, leading to drugs with fewer side effects and higher specificity.
- Therapeutic antibodies have become the leading class of new drugs, with the global market valued at $115.2 billion in 2018 and projected to reach $300 billion by 2025.
- The review highlights current market trends, key engineering technologies for developing these antibodies, and discusses future applications and growth opportunities in the field.
Top posts
Most liked on X and Blueskyこの総説は、抗体市場の最新動向と、モノクローナル抗体のヒト化までのストーリー、ファージディスプレイ、ヒト抗体マウス、単一B細胞抗体技術、抗体の変異などの抗体工学技術について。オープンアクセスです https://t.co/flGHsrDE3c https://t.co/ahOGARWlXn
この総説は、抗体市場の最新動向と、モノクローナル抗体のヒト化までのストーリー、ファージディスプレイ、ヒト抗体マウス、単一B細胞抗体技術、抗体の変異などの抗体工学技術について。オープンアクセスです https://t.co/flGHsrDE3c https://t.co/ahOGARWlXn
First, we figured out how to hack the immune system to make the antibodies we want. Now, thanks to innovative technologies, we're finding ways to produce safe, effective antibodies for all sorts of uses! Antibodies Part 2: https://t.co/oKwHk6Xai0 https://t.co/q0CQAmMsht
This what I said on 26th April, now leading hospitals of India using it.. It will help those who are not vaccinated yet and become covid positive.. @himantabiswa @keshab_mahanta @nhm_assam @abhijitsarma https://t.co/jimKHrldfN https://t.co/3yALfyA9kg
Today Professor @cehagemeyer @ACBDresearch @MonashCCS told us all about antibodies (esp phage display) and their benefit in treatment of thrombosis and stroke, check out this review https://t.co/U3TEibqr2y if you are interested https://t.co/PBKp3NebWF
All mentions
Development and Impact of Therapeutic Antibodies in Medicine
Figuring out how to hack the immune system and make the antibodies we want was just the beginning. Thanks to innovative technologies, scientists are now producing safe, effective antibodies for various uses. This video…
Monoclonal Antibodies: History, Development, and Medical Advances
This video explores the history and development of monoclonal antibodies, highlighting their structure, production methods like single B cell cloning and phage display, and their critical role in modern therapeutics. It…
Monoclonal Antibody Development and Production Overview
This video explains how monoclonal antibodies are produced, highlighting key steps and engineering advances that have improved their specificity and safety. It provides a concise overview of their significance in…
The Rise of Monoclonal Antibodies and Their Market Impact
Monoclonal antibodies are now among the most profitable drugs, with complex manufacturing that hinders generic development. This video explores their recent advancements, market value, and potential to reshape…
Advancements in Therapeutic Antibody Development for Disease Treatment
Antibody engineering has progressed significantly since 1986, resulting in drugs with higher specificity and fewer side effects. Therapeutic antibodies now dominate the pharmaceutical market, with a growing global…
Advancements in Therapeutic Antibodies for Disease Treatment
Antibody engineering has advanced since 1986, creating drugs with fewer side effects and higher specificity. Therapeutic antibodies now dominate the drug market, valued at $115.2 billion in 2018 and projected to reach…
Advancements in Therapeutic Antibodies for Disease Treatment
Antibody engineering has significantly advanced since 1986, leading to drugs with higher specificity and fewer side effects. Therapeutic antibodies are a growing market projected to reach $300 billion by 2025…
Advances in Therapeutic Antibody Development for Disease Treatment
Therapeutic antibodies have evolved significantly since 1986, offering increased specificity and fewer side effects. This video reviews current market trends, engineering technologies, and future opportunities in…
RT @Matsuda_PhDPhD: この総説は、抗体市場の最新動向と、モノクローナル抗体のヒト化までのストーリー、ファージディスプレイ、ヒト抗体マウス、単一B細胞抗体技術、抗体の変異などの抗体工学技術について。オープンアクセスです https://t.co/flGHsrD…
RT @Matsuda_PhDPhD: この総説は、抗体市場の最新動向と、モノクローナル抗体のヒト化までのストーリー、ファージディスプレイ、ヒト抗体マウス、単一B細胞抗体技術、抗体の変異などの抗体工学技術について。オープンアクセスです https://t.co/flGHsrD…
RT @Matsuda_PhDPhD: この総説は、抗体市場の最新動向と、モノクローナル抗体のヒト化までのストーリー、ファージディスプレイ、ヒト抗体マウス、単一B細胞抗体技術、抗体の変異などの抗体工学技術について。オープンアクセスです https://t.co/flGHsrD…
RT @Matsuda_PhDPhD: この総説は、抗体市場の最新動向と、モノクローナル抗体のヒト化までのストーリー、ファージディスプレイ、ヒト抗体マウス、単一B細胞抗体技術、抗体の変異などの抗体工学技術について。オープンアクセスです https://t.co/flGHsrD…
RT @Matsuda_PhDPhD: この総説は、抗体市場の最新動向と、モノクローナル抗体のヒト化までのストーリー、ファージディスプレイ、ヒト抗体マウス、単一B細胞抗体技術、抗体の変異などの抗体工学技術について。オープンアクセスです https://t.co/flGHsrD…
RT @Matsuda_PhDPhD: この総説は、抗体市場の最新動向と、モノクローナル抗体のヒト化までのストーリー、ファージディスプレイ、ヒト抗体マウス、単一B細胞抗体技術、抗体の変異などの抗体工学技術について。オープンアクセスです https://t.co/flGHsrD…
RT @Matsuda_PhDPhD: この総説は、抗体市場の最新動向と、モノクローナル抗体のヒト化までのストーリー、ファージディスプレイ、ヒト抗体マウス、単一B細胞抗体技術、抗体の変異などの抗体工学技術について。オープンアクセスです https://t.co/flGHsrD…
RT @Matsuda_PhDPhD: この総説は、抗体市場の最新動向と、モノクローナル抗体のヒト化までのストーリー、ファージディスプレイ、ヒト抗体マウス、単一B細胞抗体技術、抗体の変異などの抗体工学技術について。オープンアクセスです https://t.co/flGHsrD…
RT @Matsuda_PhDPhD: この総説は、抗体市場の最新動向と、モノクローナル抗体のヒト化までのストーリー、ファージディスプレイ、ヒト抗体マウス、単一B細胞抗体技術、抗体の変異などの抗体工学技術について。オープンアクセスです https://t.co/flGHsrD…
RT @Matsuda_PhDPhD: この総説は、抗体市場の最新動向と、モノクローナル抗体のヒト化までのストーリー、ファージディスプレイ、ヒト抗体マウス、単一B細胞抗体技術、抗体の変異などの抗体工学技術について。オープンアクセスです https://t.co/flGHsrD…
この総説は、抗体市場の最新動向と、モノクローナル抗体のヒト化までのストーリー、ファージディスプレイ、ヒト抗体マウス、単一B細胞抗体技術、抗体の変異などの抗体工学技術について。オープンアクセスです https://t.co/flGHsrDE3c https://t.co/ahOGARWlXn
この総説は、抗体市場の最新動向と、モノクローナル抗体のヒト化までのストーリー、ファージディスプレイ、ヒト抗体マウス、単一B細胞抗体技術、抗体の変異などの抗体工学技術について。オープンアクセスです https://t.co/flGHsrDE3c https://t.co/ahOGARWlXn
30 years since @US_FDA approval of first chimeric (not all murine) therapeutic #monoclonal antibody as #antiplatelet medicine for patients undergoing acute coronary intervention — ReoPro (abciximab) developed by #Centocor (now @JNJNews). https://t.co/p2zl9sOpw1
@kattitfortat @KonstantinKisin @Byoussef Here is an article about monoclonal antibodies for which the Argentinian Jew Cesar Milstein jointly won the Nobel prize for Chemistry with Georges Kohler. Despite making up 0.2% of the world population Jews are the recipients of 22% of the Nobel Prizes https://t.co/z7W2OuEGzj
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
https://t.co/ZIsx16sP3n
https://t.co/zgwxC2Fww4 @alphavestcap
@TohJah7809 I wish that were my alpaca. Here are some helpful resources for those wanting to read up on VHH antibodies, or antibody discovery in general: Twist Alpaca B-Cell Workflow https://t.co/RBH0AdSXZ8 Development of Therapeutic Antibodies https://t.co/qcqjAXkU6v
@genderaffirmed @MrTusch @abbynormal75 @GabRossi2 @JoJoFromJerz Your body. But antibodies (the soldiers created by your immune system) are needed to actually fight viruses. So, I found this very long but extremely interesting article about monoclonal antibodies. It might be hard to follow if you're unfamiliar with 3/ https://t.co/d5T92zaKKo
A super read on antibodies. https://t.co/Bocy9ORMzH
RT @Ahmad_B_Mahmoud: Development of therapeutic antibodies for the treatment of diseases https://t.co/bqBO95GgGp
RT @Ahmad_B_Mahmoud: Development of therapeutic antibodies for the treatment of diseases https://t.co/bqBO95GgGp
Development of therapeutic antibodies for the treatment of diseases https://t.co/bqBO95GgGp
Development of therapeutic antibodies for the treatment of diseases by Zeng Wang https://t.co/PWgaMoKAGz
Development of therapeutic antibodies for the treatment of diseases https://t.co/omEGkoi5rC
Development of therapeutic antibodies for the treatment of diseases https://t.co/0OKwBUWX9N
RT @MonashNeurosci: Today Professor @cehagemeyer @ACBDresearch @MonashCCS told us all about antibodies (esp phage display) and their benefi…
RT @MonashNeurosci: Today Professor @cehagemeyer @ACBDresearch @MonashCCS told us all about antibodies (esp phage display) and their benefi…
Today Professor @cehagemeyer @ACBDresearch @MonashCCS told us all about antibodies (esp phage display) and their benefit in treatment of thrombosis and stroke, check out this review https://t.co/U3TEibqr2y if you are interested https://t.co/PBKp3NebWF
Timeline from 1975 showing the successful development of therapeutic antibodies and their applications. From: https://t.co/IGxmI9KwN0 cc @chatbiology https://t.co/r4q0ORgEyx
@ExarZoze https://t.co/NvKbcYoGlN
https://t.co/AR9lujkNB1
Kdyby někoho zajímalo, jak moc nový a neprobádaný je koncept imunoterapie monoklonálními protilátkami, jak jsem se dočetl v jednom rozhovoru s odborníkem, tak tady je přehled schválených mAbs v USA. https://t.co/Y7dCfbT8Xc
Development of therapeutic antibodies for the treatment of diseases | Journal of Biomedical Science | Full Text. Monoclonal antibody research and development started before 1986. It had proven efficacy against Influenza H7N9 back in 2013.Why all the death? https://t.co/KGtNXUX1EW
RT @ChineseAntibody: An excellent review on the market trends, engineering technologies, and the future of antibody therapeutics. The first…
An excellent review on the market trends, engineering technologies, and the future of antibody therapeutics. The first and corresponding authors are Dr. Ruei-Min Lu and Dr. Han-Chung Wu from Academia Sinica, Taiwan, respectively. https://t.co/XOPrEGm9tw
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
This what I said on 26th April, now leading hospitals of India using it.. It will help those who are not vaccinated yet and become covid positive.. @himantabiswa @keshab_mahanta @nhm_assam @abhijitsarma https://t.co/jimKHrldfN https://t.co/3yALfyA9kg
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
https://t.co/OYbH89JNfx
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
RT @drkeithsiau: The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
The history of monoclonal antibodies (MAbs) - one of the most important advancements in medicine
@GaryThurner @RepRoKhanna No, OKT3 was the first to be approved, adalimumab not even the first anti-TNF mAb to be approved, infliximab was, 4 years' earlier. https://t.co/PqksTzmWpc
@LibtrianSoclist @GaryThurner @RepRoKhanna https://t.co/PqksTzmWpc https://t.co/QIB0r4yjzl He's wrong. Other mAbs approved before adalimumab, including the first targeted therapy for cancer, rituximab.
Just Liked on YouTube: Creating $122 Billion of Antibodies | Antibodies Series Part 2 https://t.co/pI7BsOAhWu
Development of therapeutic antibodies for the treatment of diseases | Journal of Biomedical Science | Full Text https://t.co/9FyeFlkddL
.@SciShow publishes daily videos about current questions from the world of science. https://t.co/Ln4609cEkm Newsletter: https://t.co/jsq9u5veag #biology #science #scishow #trivia #122Billion #Antibodies https://t.co/ZbgecSjUbL
۲ از ۳ https://t.co/O4TPwVbeM2
RT @SciShow: First, we figured out how to hack the immune system to make the antibodies we want. Now, thanks to innovative technologies, we…
Part 2 ... Creating $122 Billion of Antibodies | Antibodies Mini-Series Part 2 https://t.co/0Vlpv7dKr8 via @YouTube
Creating $122 Billion of Antibodies | Antibodies Mini-Series Part 2 https://t.co/GiRonz3Mql via @YouTube
RT @CharlesIkenna23: Creating $122 Billion of Antibodies | Antibodies Mini-Series Part 2 https://t.co/DnYhVUps0n via @YouTube
Creating $122 Billion of Antibodies | Antibodies Mini-Series Part 2 https://t.co/8XLXYyPjKY via @YouTube
RT @CharlesIkenna23: Creating $122 Billion of Antibodies | Antibodies Mini-Series Part 2 https://t.co/DnYhVUps0n via @YouTube
|・ω・`)フムフム "An Antibody for Everything : Taking Antibodies to the Next Level | Antibodies Mini-Series Part 2" on YouTube - https://t.co/OK68JGScK7
RT @SciShow: First, we figured out how to hack the immune system to make the antibodies we want. Now, thanks to innovative technologies, we…
RT @SciShow: First, we figured out how to hack the immune system to make the antibodies we want. Now, thanks to innovative technologies, we…
RT @SciShow: First, we figured out how to hack the immune system to make the antibodies we want. Now, thanks to innovative technologies, we…
An Antibody for Everything : Taking Antibodies to the Next Level | Antibodies Mini-Series Part 2 @ https://t.co/299G1kWlwf https://t.co/eaFKjnasdU
An Antibody for Everything : Taking Antibodies to the Next Level | Antib... https://t.co/ZuitzZJM48 via @YouTube
New video by SciShow: An Antibody for Everything : Taking Antibodies to the Next Level | Antibodies Mini-Series Part 2 https://t.co/mJRm7yZYfi
RT @SciShow: First, we figured out how to hack the immune system to make the antibodies we want. Now, thanks to innovative technologies, we…
First, we figured out how to hack the immune system to make the antibodies we want. Now, thanks to innovative technologies, we're finding ways to produce safe, effective antibodies for all sorts of uses! Antibodies Part 2: https://t.co/oKwHk6Xai0 https://t.co/q0CQAmMsht
An Antibody for Everything : Taking Antibodies to the Next Level | Antib... https://t.co/HoUuYCnIUJ via @YouTube
 Figs from: https://t.co/s6unodou1s https://t.co/vdwM9H5AKv https://t.co/ulwNi0tld6
RT @LeonardoSotoMu: Monoclonal Antiboides Timeline (1975-2019) Disponible en: Lu et al. Journal of Biomedical Science (2020) 27:1 https://t…
Monoclonal Antiboides Timeline (1975-2019) Disponible en: Lu et al. Journal of Biomedical Science (2020) 27:1 https://t.co/BW7GpWSv72 https://t.co/Uc1cW6V7ox
Development of therapeutic antibodies for the treatment of diseases https://t.co/710RVMvFAA
RT @Microcapbluesky: $Ipa $Ipatf Immunoprecise Antibodies Ltd . The rise of the Monoclonal Antibodies taking over from small molecule drug…
Development of therapeutic antibodies for the treatment of diseases | Journal of Biomedical Science | Full Text https://t.co/BvPwRp2NRE
RT @AutonomicAus: Development of therapeutic antibodies for the treatment of diseases, Journal of Biomedical Science (@BioMedCentral) http…
Development of therapeutic antibodies for the treatment of diseases. - PubMed - NCBI | @scoopit https://t.co/LZ9KjRn3CY
松抗
SB